Q32 Bio Inc.

NASDAQ (USD): Q32 Bio Inc. (QTTB)

Last Price

3.58

Today's Change

+0.27 (8.15%)

Day's Change

3.22 - 3.69

Trading Volume

478,004

Overview

Market Cap

43 Million

Shares Outstanding

12 Million

Avg Volume

289,891

Avg Price (50 Days)

31.19

Avg Price (200 Days)

30.40

PE Ratio

-0.80

EPS

-4.50

Earnings Announcement

11-Mar-2025

Previous Close

3.31

Open

3.27

Day's Range

3.2272 - 3.69

Year Range

3.02 - 53.79

Trading Volume

478,653

Price Change Highlight

1 Day Change

8.16%

5 Day Change

8.48%

1 Month Change

-85.73%

3 Month Change

-92.12%

6 Month Change

-76.90%

Ytd Change

-67.03%

1 Year Change

-65.18%

3 Year Change

-94.99%

5 Year Change

-99.09%

10 Year Change

-98.93%

Max Change

-98.93%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment